Up­dat­ed: Ar­bi­tra­tor awards $157M to Soon-Sh­iong's Im­mu­ni­ty­Bio in dis­pute with Sor­ren­to

Sor­ren­to Ther­a­peu­tics’ years­long bat­tle with Nant­Cell and NAN­Ti­body has come to an ar­bi­tra­tion award, but ad­di­tion­al le­gal pro­ceed­ings cen­tered around a “catch-and-kill” scheme re­main pend­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER